GPR68 Polyclonal Antibody
- Catalog No.:YT2029
- Applications:WB;IF;ELISA
- Reactivity:Human;Mouse
- Target:
- GPR68
- Gene Name:
- GPR68
- Protein Name:
- Ovarian cancer G-protein coupled receptor 1
- Human Gene Id:
- 8111
- Human Swiss Prot No:
- Q15743
- Mouse Gene Id:
- 238377
- Mouse Swiss Prot No:
- Q8BFQ3
- Immunogen:
- The antiserum was produced against synthesized peptide derived from human SPR1. AA range:281-330
- Specificity:
- GPR68 Polyclonal Antibody detects endogenous levels of GPR68 protein.
- Formulation:
- Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- Source:
- Polyclonal, Rabbit,IgG
- Dilution:
- WB 1:500 - 1:2000. IF 1:200 - 1:1000. ELISA: 1:5000. Not yet tested in other applications.
- Purification:
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Concentration:
- 1 mg/ml
- Storage Stability:
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Other Name:
- GPR68;OGR1;Ovarian cancer G-protein coupled receptor 1;OGR-1;G-protein coupled receptor 68;GPR12A;Sphingosylphosphorylcholine receptor
- Observed Band(KD):
- 41kD
- Background:
- similarity:Belongs to the G-protein coupled receptor 1 family.,
- Function:
- similarity:Belongs to the G-protein coupled receptor 1 family.,
- Subcellular Location:
- Cell membrane; Multi-pass membrane protein.
- Expression:
- Found at low level in a wide range of tissues, but significantly expressed in lung, kidney, bone and nervous system.
- June 19-2018
- WESTERN IMMUNOBLOTTING PROTOCOL
- June 19-2018
- IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL
- June 19-2018
- IMMUNOFLUORESCENCE PROTOCOL
- September 08-2020
- FLOW-CYTOMEYRT-PROTOCOL
- May 20-2022
- Cell-Based ELISA│解您多样本WB检测之困扰
- July 13-2018
- CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN
- July 13-2018
- CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN
- July 13-2018
- Antibody-FAQs
- Products Images
- Western blot analysis of lysates from Jurkat and HeLa cells, using SPR1 Antibody. The lane on the right is blocked with the synthesized peptide.